Victor Sandor
2016
In 2016, Victor Sandor earned a total compensation of $1.1M as Chief Medical Officer at Array BioPharma, a 70% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $247,500 |
|---|---|
| Option Awards | $287,435 |
| Salary | $417,917 |
| Stock Awards | $93,750 |
| Other | $79,928 |
| Total | $1,126,530 |
Sandor received $417.9K in salary, accounting for 37% of the total pay in 2016.
Sandor also received $247.5K in non-equity incentive plan, $287.4K in option awards, $93.8K in stock awards and $79.9K in other compensation.
Rankings
In 2016, Victor Sandor's compensation ranked 7,662nd out of 14,075 executives tracked by ExecPay. In other words, Sandor earned more than 45.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,662 out of 14,075 | 46th |
Division Manufacturing | 2,905 out of 5,489 | 47th |
Major group Chemicals And Allied Products | 957 out of 1,895 | 50th |
Industry group Drugs | 741 out of 1,538 | 52nd |
Industry Pharmaceutical Preparations | 590 out of 1,176 | 50th |
Source: SEC filing on September 13, 2017.
Sandor's colleagues
We found five more compensation records of executives who worked with Victor Sandor at Array BioPharma in 2016.